STOCKS TELEGRAPH

Tag: NEO

  • Neo (NEO) -What is the Chart Showing Us?

    Neo (NEO) -What is the Chart Showing Us?

    Neo coin has been very bearish since it made its All-Time High which was in May 2021. The price has been making consecutive Lower Lows and Lower Highs. This shows that the macrostructure is very bearish at the moment, and unless and until the recent Lower High doesn’t get broken, the price can’t be considered as bullish, obviously on macrostructure.

    Checking out the Weekly Time Frame first, as mentioned above, the price on the macro scale is bearish but if the last time frame to analyze is 4 Hours, then the recent candles are only much more important. The price recently broke or we can say stop hunted the Demand level, which was at $22. After that stop hunt, the price has got the orders and liquidity which serves as fuel for the price to move in any direction. This has induced some bullish momentum within the price. Last week closed bearish and rejected from the recent supply level which is very clear on the Daily Time Frame.

    So moving to the Daily Time Frame, the Supply Zone, which was mentioned above is very clear and the price reacted very beautifully from that. The rejections were great and the bearish momentum which emerged was strong as well. Now talking about the structures, the price couldn’t break the Lower High which makes it still bearish on the Daily Time Frame. Right now the reason price is again at the same Supply level could be considered as an RTO move. Now as mentioned above, the Demand Zone was broken, and this Supply zone was the one which broke it so this Supply Zone is in control at the moment so talking about the strength of this zone, it can be considered as strong.

    Now moving down to the last Time Frame which is a 4 Hour one, there are some other confluences as well, which can drive the price down. Talking about the structures, the price when it got the momentum started breaking structures to the upside but once it tapped in that supply zone, it shifted its structure to the downside which shows bearish intentions. On lower Time Frame, it also made SnD flip, which makes the 4H supply even stronger. The price right now is within the POI can short can be taken, as imbalance and liquidity below also serves as a confluence for the price to drive down.

    Invalidation point can be considered as $26 while the target can be considered as $20.

  • NEO – Where will it move Now?

    NEO – Where will it move Now?

    According to coinmarketcap, the total supply of NEO is around 100M NEO and around 70M of the NEO are in circulation at the moment. It holds the 66th rank according to market cap and has a market dominance of about 0.09%.

    At the time of writing, NEO is being traded at the price of $27.94 with a decrease of almost 6.65% in the last 24 hours. The maximum and minimum today are $30.02 and $27.34 respectively. The daily trading volume has also decreased by almost 2.28%. NEO had created its ATH in January 2018 and reached a price of almost $198.20. The price later dropped down to a price of almost $3.89 during the month of March in 2020. Since then the price has shown reversal and has been on the same trajectory since then. The price did show strength in the beginning and touched $141 in May 2021 but once again, the price is nearly at the bottom. We have seen a decrease of almost 25.47% this month.

    Technical Analysis

    It can be seen on the daily time frame that at one time, NEO was printing higher highs. A point came when even though, the price broke the structure upwards, but it dropped down once again, signaling a fake-out. The price was still bullish as long as it didn’t break the structure downwards but it eventually went down, signaling a shift in structure.

    Now the price dropped down really hard from the BOS point, this resulted in the creation of an order block. This zone is unmitigated right now. The coin at the time is falling down.

    NEO -1D

    A few days back, the price dropped down really hard and an unmitigated zone has been created. This can drive the price downwards to that level. From there we can look for a reversal and back to the order block above. At that point, we would have to look for the lower time frame for confirmations to look for a possible long or a short.

    Price Prediction – Neo

    According to the traders, NEO is a good investment and is providing a great return. Wallet investor considers NEO to be a really good investment as well. According to them, in a year the price is expected to reach a value of $58.649. In five years the price is expected to reach a value of $182.703.

  • NEO coin price prediction – Growth towards $60

    NEO coin price prediction – Growth towards $60

    Like all major cryptocurrencies, Neo (NEO) has been suffering from bearish momentum too. Neo coin is struggling with upholding bullish momentum and it has entered into an indecisive phase with decreased volatility. The cryptocurrency stands at a price level of $35. The price has increased only slightly in the past twenty-four hours while the trading volume is declining.

    The market outlook for Neo continues to be bearish with majority of the technical indicators giving out a bearish signal. Out of the total twenty-six technical indicators, eleven are standing at a sell position while ten are giving out a neural indication and only five are indicating a buy position. The oscillators are strongly bullish while the moving averages are strongly bearish.

    Neo (NEO) price prediction

    Wallet Investor’s forecasts predict Neo crypto to be operating at a price level of $62 in a year’s time while the five-year projection shows Neo at $186. Trading beasts expects an increase in the price of Neo as well. Per their estimates, Neo will be operating at a price level of $45 by the end of 2022 but the price will gradually climb to $60 by 2024. Neo is considered a good investment in the long-term with potential to go higher.

    What is Neo?

    Neo (NEO), originally called AntShares, is considered as China’s first public blockchain project. Emerging from China, Neo takes a place on the good side of regulators as the Chinese regulators are extremely hard on cryptocurrencies.

    The purpose of Neo is the automation of digital assets by employing the smart contracts technology. But that is not all! Neo aims to create a smart technology with smart contracts, digital assets and digital identities. The distributed-network based smart economy is regarded as the future of the world as the globe moves towards digitization.

  • Neo (NEO) coin nearing strong resistance at $77

    Neo (NEO) coin nearing strong resistance at $77

    Neo (NEO) stands at a price level of $58, at the time of writing. During the bull run of 2021, NEO coin could not break its all-time high of $196 established during 2018. It did, however, reach towards $140 as its 52-week high. The cryptocurrency has fallen nearly 60% from its high of the 2021 bull run. In the daily timeframe, Neo coin appears to be continuing its downward trend with the price decreasing since the past day. The daily trading volume is also on a downtrend.

    Neo (NEO) Technical Analysis

    The market sentiment for Neo crypto is bearish – as is a majority of the crypto market. On a downward bias, technical indicators for the cryptocurrency are majorly suggesting sell signals. Out of the twenty-six on-site technical indicators, twelve suggest a sell, ten are standing at a neutral position while only four are giving out a buy signal. The oscillators are neutral while the moving averages are suggesting a strong fall in the price level.

    Neo coin is expected to soon reverse its downward trajectory. A trader has identified the price level of $35 as strong support. The cryptocurrency experienced a pullback from the support level amidst the market crash – indicating its strength. The trader has also identified strong resistance lying at $77 which stands parallel to the 0.618 Fibonacci retracement level. The cryptocurrency will see 48% growth if it is able to reach towards the resistance level and stabilize in the region.

    Evolution of Neo blockchain: N3

    N3 is a version of the Neo blockchain said to represent “bold, refined, simple and powerful”, It is the next step in the evolution of the Neo blockchain which will take it closer to Neo’s mission of becoming the most complete blockchain available. N3 is not to be confused with a newer blockchain but rather it is a newer upgrade for the Neo blockchain. It will be launched on a new chain resulting in two versions of blockchain running simultaneously. The N3 may be the stepping stone in the journey of the Neo blockchain.

  • Neo (NEO) price prediction: Headed towards $2,000?

    Neo (NEO) price prediction: Headed towards $2,000?

    Neo (NEO) has its all-time high at $196 established in 2018, however, the coin has been operating in single digits ever since the ATH was formed. Where investors had regarded Neo coin to have a price level in single digits only, the cryptocurrency surprised everyone as it shot up towards $133 in the bull run of 2021. The year-to-date returns on Neo coin are at a whopping 530%. At the time of writing, Neo crypto stands at a price level of $90. The price has gone up in the past twenty-four hours while the trading volume has decreased by 20%.

    Neo (NEO) Technical Analysis

    The market sentiment for Neo coin is bullish. Out of the 26 total technical indicators, fifteen are standing at a buy position with eight indications of neutral and only three signals of sell. The oscillators and moving averages are both giving out bullish signals.

    Neo (NEO) Technical Analysis
    Neo (NEO) Technical Analysis

    A trader has identified Neo coin to be operating in an ascending channel formation. Per the trader, Neo crypto has bounced off the support – the lower boundary of the channel formation – multiple times which has it established very strong support. The trader is bullish on the cryptocurrency. Analyzing the Relative Strength Index, the trader commented that the RSI is much lower than the all-time high of 96 which means there is room to grow for Neo coin.  The trader is expecting brief pullbacks inside the ascending channel but ultimately for the coin to reach towards the resistance at the upper boundary – at the price level of $2,000 – after which an upside exit from the channel is expected.

    Neo coin price prediction

    The trader’s $2,000 price target may be too optimistic for the coin at the moment as other estimates do not put Neo anywhere close to that level. According to the prediction of Wallet Investor, Neo will be priced at $100 in a year’s time and just at $183 in five years’ time. Trading Beasts forecasts the cryptocurrency to operate at an average price of $78 towards the end of 2021 while the price at the end of 2022 is expected to be near $100. Digital Coin Price has the most optimistic price prediction as of yet and places Neo coin at $400 in five years’ time.

  • 15 Trending Stocks To Watch In Diagnostics And Research Industry

    15 Trending Stocks To Watch In Diagnostics And Research Industry

    The Diagnostic Research Industry is playing an integral part in the medical evaluation and treatment of patients.  This industry is vital to the healthcare market as it is providing information related to the severity and causes of illnesses in patients to healthcare practitioners. The changes we are witnessing in today’s healthcare industry are setting the goal for evolution we will see over the next decade.

    There are major drivers that are changing and will change the direction of this industry in present and future as well. The first driver is technology. As time passes by, new technologies are emerging and playing a very important role in the healthcare industry. In today’s world, patients want easier access to care and demand better service. The demand for this industry is linked to the number of patients receiving the treatment. The profitability and growth of the company depend on good marketing and efficient operations.

    Let check these 15 companies in Diagnostic Research Industry to know more about this industry and the trends this industry is following:

    Interpace Biosciences Inc. (NASDAQ: IDXG)

    Interpace Biosciences Inc. (NASDAQ: IDXG) shares were trading up 32.89% at $3.96 at the time of writing on Wednesday. Interpace Biosciences Inc. (NASDAQ: IDXG) share price went from a low point around $2.57 to briefly over $11.00 in the past 52 weeks, though shares have since pulled back to $3.96. IDXG market cap has remained high, hitting $15.88M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Interpace Biosciences Inc. (NASDAQ: IDXG) has announced that the Audit Committee has disclosed the result of an independent investigation. The committee has completed the investigation with the statement that the allegations made in the complaints were unverified and there is no truth behind them. investigation and If we look at the recent analyst rating IDXG, Janney initiated coverage on IDXG shares with a Buy rating.

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) last closed at $4.07, in a 52-week range of $1.12 to $6.47. Analysts have a consensus price target of $8.00. OPKO Health Inc. (OPK) disclosed it plans to report operating and financial results for the three months ended September 30, 2020, as well as discuss financial guidance, after the close of the U.S. financial markets on Thursday, October 29, 2020.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) stock drop by -6.29% to $49.28. The most recent rating by JP Morgan, on October 14, 2020, is at a Neutral. Invitae Corporation (NVTA) disclosed that on October 2, 2020, it has executed the transaction to bring ArcherDX into Invitae to create a comprehensive offering that provides testing services for disease risk, therapy optimization, and personalized cancer monitoring to enable precision approaches to cancer treatment.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) shares headed rising, higher as much as 0.07%. The most recent rating by JP Morgan, on October 02, 2020, is at an Overweight. Pacific Biosciences of California Inc. (PACB) has disclosed that collaborated with Children’s Mercy Kansas City to further understand the most challenging pediatric diseases. The companies will join forces to sequence a statistically significant cohort of rare disease cases for which previous whole-genome and whole-exome sequencing studies yielded no answers.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) fall -0.15% after losing more than $0.0 on Wednesday. Bionano Genomics Inc. (BNGO) revealed today that it is scheduled to release financial results of the third quarter ended September  30, 2020, on November 12, 2020. The company will also hold the conference call on the same day.

    T2 Biosystems Inc. (NASDAQ: TTOO)

    T2 Biosystems Inc. (NASDAQ: TTOO) stock drop by 0.00% to $1.33 after T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020. The most recent rating by BTIG Research, on October 08, 2020, is at a Buy.  T2 Biosystems Inc. (TTOO) market capitalization has remained high, hitting $196.79 million at the time of writing.

    NeoGenomics Inc. (NASDAQ: NEO)

    NeoGenomics Inc. (NASDAQ: NEO) Shares headed rising, higher as much as 5.46%. The most recent rating by Morgan Stanley, on September 09, 2020, is at an Overweight. NeoGenomics Inc. (NEO) revealed its plans to open a state-of-the-art research laboratory in China in association with the new lab PPD, Inc. (NASDAQ: PPD) is opening in Suzhou.

    PerkinElmer Inc. (NYSE: PKI)

    PerkinElmer Inc. (NYSE: PKI) fall -2.10% after losing more than -$2.62 on Wednesday. PerkinElmer Inc. (PKI) earlier announced that it is expected to report organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020.

    Chembio Diagnostics Inc. (NASDAQ: CEMI)

    Chembio Diagnostics Inc. (NASDAQ: CEMI) last closed at $4.77, in a 52-week range of $2.25 to $15.89. Analysts have a consensus price target of $5.00. Chembio Diagnostics Inc. (CEMI) disclosed earlier that the U.S. Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application for the DPP HIV-Syphilis System.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) Shares headed falling, lower as much as -4.35%. The most recent rating by Guggenheim, on October 13, 2020, is at a Neutral. Illumina Inc. (ILMN) has earlier announced that it is scheduled to release the third quarter 2020 following the close of the market on Thursday, October 29, 2020.

    Enzo Biochem Inc. (NYSE: ENZ)

    Enzo Biochem Inc. (NYSE: ENZ) fall -17.24% after losing more than -$0.45 on Wednesday. Enzo Biochem Inc. (ENZ) earlier reported financial results for the fourth quarter and full-year ended July 31, 2020, and provided a business update on recent corporate and operational developments.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) last closed at $38.17, in a 52-week range of $6.70 to $52.47. Analysts have a consensus price target of $56.25. Fulgent Genetics Inc. (FLGT) disclosed earlier that the Ohio Department of Rehabilitation and Correction (“ODRC”) has selected Fulgent Genetics for their COVID-19 testing needs.

    QIAGEN N.V. (NYSE: QGEN)

    QIAGEN N.V. (NYSE: QGEN) stock drop by -0.11% to $52.37. The most recent rating by BofA Securities, on October 06, 2020, is at a Buy. QIAGEN N.V. (QGEN) earlier announced preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020. It has shared that the Net sales grew 26% at actual rates, and also rose 26% at constant exchange rates (CER) $481.3 million from $382.7 million in the same period of 2019.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) last closed at $6.89, in a 52-week range of $1.17 to $12.45. Fluidigm Corporation (FLDM) has moved up 488.03% from its 52-weeks low and moved down -44.74% from its 52-weeks high. Looking at its liquidity, it has a current ratio of $509.65 million at the time of writing.

    Danaher Corporation (NYSE: DHR)

    Danaher Corporation (NYSE: DHR) stock soar by 0.41% to $226.55. The most recent rating by Wolfe Research, on June 16, 2020, is at an Outperform. Danaher Corporation (DHR) share price went from a low point around $119.60 to briefly over $227.48 in the past 52 weeks, though shares have since pulled back to $222.59. DHR  market cap has remained high, hitting $156.91 billion at the time of writing.